Feature Category Subscribe to RSS Feed

DNA

Helmsley Grant to UFDI to Study Immune Repertoire in T1D

Published: Nov 16th, 2018

University of Florida and Kings College London have secured a $3.7 million grant funded by Adaptive Biotechnologies and the Leona M. and Harry B. Helmsley Charitable Trust to profile T […]

TIGIT

Join Our Mission

Published: Jul 22nd, 2018

The Brusko Lab is currently recruiting a Postdoc to work on our NIH R01 “The CD226 and TIGIT Costimulatory Axis in Type 1 Diabetes.”

TrialNet

ATG Preserves β-Cell Function in Clinical Trial

Published: Jul 22nd, 2018

The 1-year C-peptide was significantly higher (β-cell preservation) in subjects treated with ATG versus placebo (P = 0.0003) but not in those treated with ATG/GCSF versus placebo (P = 0.031).

Figure 2

What’s your GRS?

Published: Mar 15th, 2018

The Brusko Lab and collaborators are trying to better understand how genes influence T1D risk

Our Research Focus

Published: Mar 11th, 2012

Our laboratory aims to harness the power of naturally occurring regulatory T cells to correct unwanted immune responses that deliver a cure for type 1 diabetes.

Peeps

Our Staff

Published: Mar 7th, 2012

From undergraduate students to post-doctoral fellows – every set of hands is important.

Our Publications

Published: Mar 6th, 2012

View how Dr. Brusko’s research has progressed and see where our research currently stands.

Our Space

Published: Mar 5th, 2012

The Brusko Lab enjoys being a part of UFHealth and the UF Diabetes Institute in Gainesville, Florida.